NMV Stock Overview
Engages in the retail sale of cannabis products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Captor Capital Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.56 |
| 52 Week High | CA$2.60 |
| 52 Week Low | CA$0.0075 |
| Beta | 0.36 |
| 11 Month Change | -14.50% |
| 3 Month Change | 14.75% |
| 1 Year Change | -14.18% |
| 33 Year Change | -95.42% |
| 5 Year Change | n/a |
| Change since IPO | -99.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| NMV | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 4.7% | -1.0% | 0.2% |
| 1Y | -14.2% | -19.3% | 8.5% |
Return vs Industry: NMV exceeded the German Pharmaceuticals industry which returned -20.1% over the past year.
Return vs Market: NMV underperformed the German Market which returned 8.2% over the past year.
Price Volatility
| NMV volatility | |
|---|---|
| NMV Average Weekly Movement | 625.4% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: NMV's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: NMV's weekly volatility has decreased from 813% to 625% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 78 | John Zorbas | captorcapital.com |
Captor Capital Corp. engages in the retail sale of cannabis products in the United States. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. on June 2, 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.
Captor Capital Corp. Fundamentals Summary
| NMV fundamental statistics | |
|---|---|
| Market cap | €1.91m |
| Earnings (TTM) | €13.30m |
| Revenue (TTM) | €40.33m |
0.1x
P/E Ratio0.0x
P/S RatioIs NMV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NMV income statement (TTM) | |
|---|---|
| Revenue | CA$58.70m |
| Cost of Revenue | CA$14.93m |
| Gross Profit | CA$43.77m |
| Other Expenses | CA$24.41m |
| Earnings | CA$19.36m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.57 |
| Gross Margin | 74.56% |
| Net Profit Margin | 32.98% |
| Debt/Equity Ratio | 0% |
How did NMV perform over the long term?
See historical performance and comparison